Edit Symbol List
MATK: Stock Quote & Summary Data
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | $ 29.50 |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 344,338 |
| Previous Close | $ 17.37 |
| 52 Wk High / Low | $ 31.35 / $ 15.36 |
| Shares Outstanding | 33,239,000 |
| Market Value | $ 601,958,290 |
| P/E Ratio | 15.61 |
| Forward P/E (1yr) | 12.39 |
| Earnings Per Share | $ 1.16 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.8 |
| NASDAQ Official Open Price: | $ 17.18 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 18.11 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About MATK?
Ask your question about about Martek Biosciences Corporation (MATK) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces life’sDHA™, a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in infant formula, perinatal products, foods and beverages and dietary supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. NUTRITIONAL PRODUCTS We have developed production methods and intellectual property for two important fatty acids. These fatty acids are DHA and ARA. We sell oils containing these fatty acids under the names DHASCO®, life’sDHA™, Neuromins® and ARASCO®. We derive DHA from microalgae and ARA from fungi, using proprietary processes. Cell membranes throughout the body contain these fatty acids, and they are particularly concentrated in the brain, central nervous system, retina and heart. ... More ...
Links to all Martek Biosciences Corporation (MATK) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for MATK |
||
|
Martek Biosciences To Present At The Canaccord Adams Healthy Living Conference At 8:30 AM - RTT News 09/23/2009 7:59AM |
||
|
Martek's life'sDHA(TM) Featured in New Nutrioli DHA Cooking Oil from Ragasa - PR Newswire 09/21/2009 3:55PM |
||
|
Martek Biosciences Announces Election Of David Pernock To Board Of Directors - Quick Facts - RTT News 09/16/2009 5:13PM |
||
|
Martek Announces Addition to Its Board of Directors - PR Newswire 09/16/2009 4:57PM |
||
|
Martek to Present at Two Upcoming Investor Conferences - PR Newswire 09/15/2009 9:00AM |
||
|
Martek Announces Settlement of Patent Dispute with Capsugel France - PR Newswire 09/10/2009 9:45AM |
||
|
Federal Circuit Rules in Martek's Favor in Appeal of Patent Infringement Case - PR Newswire 09/08/2009 6:03PM |



Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
4.26%
